Deltex Medical Group plc (LON:DEMG) has signed up two more US hospitals for its bloodflow monitoring systems including its first major account in a veterans’ hospital.
There are 20 US hospitals using Deltex’s oesophageal Doppler monitoring (ODM) probes in sufficient quantities to be deemed ‘platform’ programme accounts.
The new accounts are with hospitals in the Mid-West and the Veterans Affairs (VA) hospital.
Taxpayer funded, the VA system is the largest integrated health system in the US with over 150 medical centres across the US and including hospitals in most major cities.
Both new hospitals have indicated that they expect to start implementation this month at around 50 probes a month and to expand usage over time.
Ewan Phillips, Deltex Medical's chief executive, said: “Getting to 20 platform programme accounts is an important step towards delivering Deltex's US expansion strategy.
“Establishing a first platform programme account in the VA system is in itself also a major development."
Deltex has a target of 30 platform accounts in the US by the middle of the year.